Apontis Pharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Institutions | 1,434,100 | 17.2% |
VC/PE Firms | 3,230,000 | 38.8% |
General Public | 3,665,900 | 44% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
3,230,000 | €26.7m | 0% | no data | |||
455,936 | €3.8m | 0% | 2.52% | |||
248,769 | €2.1m | -16% | no data | |||
207,460 | €1.7m | -5.11% | no data | |||
125,000 | €1.0m | 0% | 0.07% | |||
123,244 | €1.0m | 0% | 0.14% | |||
71,962 | €594.4k | 0% | 0.08% | |||
52,526 | €433.9k | 0% | no data | |||
52,116 | €430.5k | 0% | 0.51% | |||
36,342 | €300.2k | 0% | 0.06% | |||
30,000 | €247.8k | 0% | 0.06% | |||
13,000 | €107.4k | 0% | 0.01% | |||
10,000 | €82.6k | 0% | 0.05% | |||
7,745 | €64.0k | 0% | 0.03% |